Smith Hunter C (CIK 1636385) reported 43 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-01). Recent activity: Buy RYTM (57,187 shares), Sell RYTM (23,072 shares), Sell RYTM (11,514 shares), Sell RYTM (28,188 shares), Buy RYTM (3,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-01 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Buy | 57,187 | $1.5M |
| 2026-09-01 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Sell | 23,072 | $2.4M |
| 2026-09-01 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Sell | 11,514 | $1.2M |
| 2026-09-01 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Sell | 28,188 | $3.0M |
| 2026-05-20 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Buy | 3,000 | $53,610 |
| 2026-03-02 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Buy | 6,099 | $41,473 |
| 2026-02-19 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Sell | 1,692 | $170,757 |
| 2026-02-19 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Sell | 200 | $20,104 |
| 2026-02-19 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Sell | 900 | $91,530 |
| 2026-02-19 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Sell | 1,069 | $110,107 |
| 2026-02-19 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Sell | 200 | $20,768 |
| 2026-02-19 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Sell | 1,308 | $131,153 |
| 2026-02-19 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Sell | 1,200 | $119,304 |
| 2026-02-19 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Sell | 800 | $81,680 |
| 2026-02-19 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Sell | 585 | $60,419 |
| 2026-02-12 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Sell | 1,913 | $196,389 |
| 2026-02-12 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Sell | 700 | $72,576 |
| 2026-02-12 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Sell | 100 | $10,476 |
| 2026-02-12 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Sell | 2,266 | $222,906 |
| 2026-02-12 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Sell | 400 | $39,776 |
| 2026-02-12 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Sell | 100 | $10,085 |
| 2026-02-12 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Sell | 292 | $28,108 |
| 2026-02-12 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Sell | 400 | $39,068 |
| 2026-02-12 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Sell | 800 | $79,192 |
| 2026-02-12 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | Sell | 100 | $10,010 |
来源：SEC Form 4 申报文件 · 截至 2026-09-01